Efficacy and Safety of Intravenous Neridronic Acid in CRPS
Status:
Terminated
Trial end date:
2019-07-31
Target enrollment:
Participant gender:
Summary
The aim of this trial was to investigate the efficacy and safety of intravenous neridronic
acid in subjects with Complex Regional Pain Syndrome (CRPS).
The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A
consisting of 4 infusions (neridronic acid or placebo) over 10 days, and a Follow-up Period 1
until Week 26.
At Week 26, participants not meeting the pre-specified criteria to continue into Treatment
Period B continued in Follow-up Period 2 until Week 52. Participants meeting the
pre-specified criteria entered the open-label Treatment Period B with 4 additional infusions
(neridronic acid) over 10 days and follow-up visits until Week 52.